Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues
- PMID: 16804749
- PMCID: PMC5096443
- DOI: 10.1007/s10461-006-9133-3
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues
Abstract
We explored methodological issues related to antiretroviral adherence assessment, using 6 months of data collected in a completed intervention trial involving 136 low-income HIV-positive outpatients in the Bronx, NY. Findings suggest that operationalizing adherence as a continuous (versus dichotomous) variable and averaging adherence estimates over multiple assessment points (versus using only one) explains greater variance in HIV-1 RNA viral load (VL). Self-reported estimates provided during a phone interview accounted for similar variance in VL as EDM estimates (R (2) = .17 phone versus .18 EDM). Self-reported adherence was not associated with a standard social desirability measure, and no difference in the accuracy of self-report adherence was observed for assessment periods of 1-3 days. Self-reported poor adherence was more closely associated with EDM adherence estimates than self-reported moderate and high adherence. On average across assessment points, fewer than 4% of participants who reported taking a dose of an incorrect amount of medication.
Figures
Similar articles
-
Validation of a New Three-Item Self-Report Measure for Medication Adherence.AIDS Behav. 2016 Nov;20(11):2700-2708. doi: 10.1007/s10461-016-1406-x. AIDS Behav. 2016. PMID: 27098408 Free PMC article.
-
A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China.AIDS Behav. 2011 Jul;15(5):919-29. doi: 10.1007/s10461-010-9828-3. AIDS Behav. 2011. PMID: 20957423 Free PMC article. Clinical Trial.
-
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.Eur J Clin Pharmacol. 2007 Dec;63(12):1115-21. doi: 10.1007/s00228-007-0369-2. Epub 2007 Sep 20. Eur J Clin Pharmacol. 2007. PMID: 17882408 Free PMC article. Clinical Trial.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.J Infect Dis. 2002 May 15;185 Suppl 2:S143-51. doi: 10.1086/340197. J Infect Dis. 2002. PMID: 12001036 Review.
Cited by
-
Self-compassion and reactions to serious illness: the case of HIV.J Health Psychol. 2014 Feb;19(2):218-29. doi: 10.1177/1359105312467391. Epub 2013 Jan 8. J Health Psychol. 2014. PMID: 23300046 Free PMC article.
-
Community Efficacy for Non-Communicable Disease Management and Medication Adherence: The Sequential Mediating Role of Self-Efficacy and Depressive Symptoms.Patient Prefer Adherence. 2023 Dec 14;17:3421-3433. doi: 10.2147/PPA.S436419. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 38111691 Free PMC article.
-
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?Clin Med Insights Oncol. 2016 Oct 2;10:95-104. doi: 10.4137/CMO.S32822. eCollection 2016. Clin Med Insights Oncol. 2016. PMID: 27721664 Free PMC article.
-
Alcohol-related intentional nonadherence to antiretroviral therapy among people living with HIV, Cape Town, South Africa.AIDS Care. 2019 Aug;31(8):951-957. doi: 10.1080/09540121.2019.1587357. Epub 2019 Mar 18. AIDS Care. 2019. PMID: 30884956 Free PMC article.
-
Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study.Patient Prefer Adherence. 2013 Aug 1;7:729-39. doi: 10.2147/PPA.S47519. eCollection 2013. Patient Prefer Adherence. 2013. PMID: 23983457 Free PMC article.
References
-
- Ammassari A, Trotta M, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes. 2002;31:S123–S127. - PubMed
-
- Bangsberg DR. U.S. researcher starts treatment fund in Uganda: Interview with David Bangsberg, M.D., M.P.H. AIDS Treatment News. 2004;(402):3–5. - PubMed
-
- Bangsberg DR, Bronstone A, Chesney MA, Hecht FM. Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal of Acquired Immune Deficiency Syndromes. 2002;31(3):S107–S111. - PubMed
-
- Bangsberg DR, Hecht FM, Charlebois ED, Chesney MA, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior. 2001;5:272–281.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical